tradingkey.logo
搜索

DarioHealth Corp

DRIO
添加自选
7.280USD
+0.570+8.49%
收盘 07/02, 13:00美东报价延迟15分钟
53.14M总市值
亏损市盈率 TTM

DarioHealth Corp

7.280
+0.570+8.49%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+8.49%

5天

+3.56%

1月

-4.21%

6月

-41.99%

今年开始到现在

-36.03%

1年

-48.35%

关键数据
6.895今开
8.000最高
61.00K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.84%换手率
6.750昨收
6.895最低
333.82K成交额
亏损市盈率静
0.85市净率
0.00%股息率 TTM
-37.22%ROA
17.74452周最高
3.84量比
-40.98M净利润
7.30M总股本
-13.8842每股收益TTM
1.10Beta
-92.87%ROE
5.93552周最低
16.37%振幅
57.31%毛利率
53.14M总市值
-1.69回报/风险
6.62%风险率

TradingKey DarioHealth Corp股票评分

单位: USD 更新时间: 2026-07-02

操作建议

DarioHealth Corp当前公司基本面数据相对健康,增长潜力稳定。当前估值合理,在医疗设备与耗材行业排名105/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价18.50。中期看,股价处于上升通道。近一个月,市场表现一般,但技术面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

DarioHealth Corp评分

相关信息

行业排名
105 / 204
全市场排名
253 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

DarioHealth Corp亮点

亮点风险
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
业绩增长期
公司处于发展阶段,最新年度总收入22.36M美元
估值高估
公司最新PE估值-0.52,处于3年历史高位
机构减仓
最新机构持股782.90K股,环比减少22.05%

分析师目标

根据 4 位分析师
买入
评级
18.500
目标均价
+154.12%
涨幅空间

DarioHealth Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

DarioHealth Corp简介

DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
公司代码DRIO
公司DarioHealth Corp
CEORaphael (Erez)
网址https://shop.mydario.com/

常见问题

DarioHealth Corp(DRIO)的当前股价是多少?

DarioHealth Corp(DRIO)的当前股价是 7.28。

DarioHealth Corp的股票代码是什么?

DarioHealth Corp的股票代码是DRIO。

DarioHealth Corp股票的52周最高点是多少?

DarioHealth Corp股票的52周最高点是17.74。

DarioHealth Corp股票的52周最低点是多少?

DarioHealth Corp股票的52周最低点是5.93。

DarioHealth Corp的市值是多少?

DarioHealth Corp的市值是53.14M。

现在DarioHealth Corp(DRIO)的股票是买入、持有还是卖出?

根据分析师评级,DarioHealth Corp(DRIO)的总体评级为买入,目标价格为18.50。

DarioHealth Corp(DRIO)股票的每股收益(EPS TTM)是多少

DarioHealth Corp(DRIO)股票的每股收益(EPS TTM)是-15.50。